Net Cash Provided by (Used in) Operating Activities |
-7.69K |
USD |
+84.6% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
46M |
shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Sep 30, 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.47K |
USD |
-72.5% |
Sep 30, 2023 |
Q3 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
97K |
USD |
+31.1% |
Dec 31, 2022 |
Q4 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
97K |
USD |
+31.1% |
Dec 31, 2022 |
Q4 2022 |
Current Income Tax Expense (Benefit) |
-38K |
USD |
+30.9% |
Dec 31, 2022 |
Q4 2022 |
Additional Paid in Capital |
215K |
USD |
0% |
Sep 30, 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Interest Expense |
6.7K |
USD |
+70.3% |
Sep 30, 2023 |
Q3 2023 |